GLP-1 drugs are under scrutiny due to potential risks and their expanding use. The medications have shown benefits for heart health, but studies have also found limitations and potential negative impacts on life quality. The extent of the risks, including a possible link to pancreatitis, is being examined and monitored, including at a recent major sporting event.